Le Lézard
Classified in: Health
Subject: PDT

KAV Health Group Launches Innovative Mental Health Day Treatment Program in Dayton


DAYTON, Ohio, May 20, 2024 /PRNewswire/ -- KAV Health Group, LLC, a premier provider of comprehensive mental health services, is excited to announce the opening of its new Mental Health Day Treatment Facility at 5563 Far Hills Ave, Dayton. 

This program, starting May 1st, 2024, enhances KAV's robust suite of mental health and psychiatric treatments, providing a critical service for those needing structured but non-residential care.

The Day Treatment program offers a flexible yet intensive therapeutic environment, allowing patients to engage in group therapy, individual counseling, and medication management during the day and return home at night. Designed for patients requiring more support than typical outpatient services, this program fills a vital gap in the continuum of care.

Kimberly Handegard, Executive Director at KAV Health Group, emphasizes the program's importance: "At KAV, we are dedicated to bridging the gap in mental health services with innovative solutions that cater to the needs of our community. Our new Day Treatment facility is a testament to our commitment to accessible, high-quality care, providing a structured, therapeutic environment that supports our clients on their journey to recovery."

KAV Mental Health & Psychiatry, known for its patient-centric approach, is offering personalized treatment plans developed by mental health professionals. The facility will integrate various treatment modalities to cater to different mental health disorders, focusing on medication-assisted treatment (MAT), individualized therapy, and innovative telehealth services.

About KAV Health Group, LLC 

KAV Health Group, LLC, is a trusted mental health and addiction treatment provider that serves clients in Ohio with proven methods such as cognitive behavioral therapy and medicated assisted treatment (MAT) programs. KAV Health Group offers its patients a comprehensive approach to mental health and addiction and focuses on healing and growth. Clients at KAV Health Group start with a comprehensive medical assessment before its experienced team of mental health experts customize a treatment plan for each client's specific needs.

For more information about the Mental Health Day Treatment program,
please contact:
 

KAV Health Group Media Relations
5563 Far Hills Ave
Dayton, OH 45429
Phone: (844) KAV-LIFE (844) 528-5433
Email: [email protected]
Websites: 
https://kavmentalhealth.com
https://kavrecovery.com

SOURCE KAV Health Group


These press releases may also interest you

at 22:15
2Flo Ventures, an emerging venture capital firm and startup studio focused on the discovery, development, and commercialization of healthcare solutions that address disparities in outcomes and health equity broadly, is pleased to announce the...

at 22:00
LaVie Care Centers, LLC (the "Company"), an operator of 43 licensed skilled nursing facilities in five states, today announced that it has taken steps to implement a financial restructuring designed to improve its capital structure and position the...

at 21:41
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune, ophthalmology and other major...

at 21:30
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...

at 21:19
China Medical University Hospital (CMUH, Taiwan) and the Malaysian International Medical University (IMU), the first and top private medical and health science university in Malaysia, jointly signed a memorandum of understanding (MOU) on...

at 21:14
Keymed Biosciences Inc. (HKEX: 02162) today announced the long-term efficacy and safety data of a Phase III clinical trial of stapokibart injection in patients with moderate-to-severe atopic dermatitis (AD) has been released by way of oral...



News published on and distributed by: